SO
64
4
AES
58
3
HBAN
47
2
UA
59
2
FOX
42
2
CL
62
3
FTI
76
5
HAL
50
4
IPG
42
2
CMS
67
2
FAST
46
-2
NWSA
58
4
EXPD
61
2
ADT
43
-3
UNH
57
4
FMC
40
-10
COP
47
7
CPB
55
-2
ISRG
66
-2
CVX
40
8
SO
64
4
AES
58
3
HBAN
47
2
UA
59
2
FOX
42
2
CL
62
3
FTI
76
5
HAL
50
4
IPG
42
2
CMS
67
2
FAST
46
-2
NWSA
58
4
EXPD
61
2
ADT
43
-3
UNH
57
4
FMC
40
-10
COP
47
7
CPB
55
-2
ISRG
66
-2
CVX
40
8
Financhill
Back

Perion Network Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
48

PERI
Perion Network

Last Price:
7.96
Seasonality Move:
15.13%
Sell
36

SRPT
Sarepta Therapeutics

Last Price:
124.65
Seasonality Move:
-1.39%
Sell
48
Perion Network (PERI) is a Sell

Is Perion Network a Buy, Sell or Hold?

  • The current Perion Network [PERI] share price is $7.97. The Score for PERI is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • PERI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
36
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $124.53. The Score for SRPT is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PERI Stock Price Chart

What is Perion Network's stock price today?

  • The Perion Network share price today is $7.97
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PERI is experiencing selling pressure, which indicates risk of future bearish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $124.53
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight selling pressure.

PERI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.13 Sell
Relative Strength Index (14 RSI): 43.59 Sell
Chaikin Money Flow: -140626 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.01 - 8.49) Sell
Bollinger Bands (100): (7.69 - 10.89) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.18 Sell
Relative Strength Index (14 RSI): 35.54 Sell
Chaikin Money Flow: -49995 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (124.27 - 135.95) Sell
Bollinger Bands (100): (123.89 - 147.49) Sell

PERI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 8.05 Sell
20-day SMA: 8.16 Sell
50-day SMA: 8.36 Sell
200-day SMA: 16.24 Sell
8-day EMA: 8.04 Sell
20-day EMA: 8.16 Sell
50-day EMA: 8.57 Sell
200-day EMA: 14.74 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 125.45 Sell
20-day SMA: 127.75 Sell
50-day SMA: 135.2 Sell
200-day SMA: 127.53 Sell
8-day EMA: 125.39 Sell
20-day EMA: 128.04 Sell
50-day EMA: 132.59 Sell
200-day EMA: 128.64 Sell

Perion Network Earnings Growth & PERI Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.54 per share, an increase next quarter of $0.04 per share, a decrease this year of $1.92 per share, and a decrease next year of $0.11 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.96 per share, an increase next quarter of $2.81 per share, an increase this year of $4.41 per share, and an increase next year of $9.14 per share.

Perion Network Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):